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Abstract
Background and Aims
Neuropilin 1 (NRP1) is a non-tyrosine kinase receptor for vascular endothelial growth factor
(VEGF) and class 3 semaphorins, playing a role in angiogenesis and neuronal axon guid-
ance, respectively. NRP1 is expressed in smooth muscle cells (SMC) but the functional role
of NRP1 in SMC has not been elucidated. We therefore investigated the biological rele-
vance of NRP1 in SMC in vivo by generating mice with SMC-specific Nrp1 deficiency.
Methods
Conditional gene targeting generated SMC-specific Nrp1 knockout mice (Nrp1SMKO) in
which Cre recombinase is driven by the smooth muscle-specific myosin heavy chain
(smMHC) promoter.
Results
SMC-specific Nrp1 deficiency resulted in a significant reduction in intestinal length by
6 months, and, by 18 months, in severe constipation, and enlargement of the intestine
consistent with chronic intestinal pseudo-obstruction. These effects were associated with
significant thinning of the intestinal smooth muscle, and decreased intestinal contractility.
Expression of contractile proteins was reduced in Nrp1SMKOmice, including the smMHC
isoform, SMB, whereas we observed a significant increase in the expression of the small-
conductance calcium-activated potassium channel 3 (SK3/KCa2.3), implicated in negative
regulation of smooth muscle contraction.
Conclusions
Nrp1 deficiency in visceral SMC results in adult-onset defects in gastrointestinal contractility
and motility and causes a shift to a less contractile SMC phenotype. These findings indicate
a new role for Nrp1 in the maintenance of the visceral SMC contractile phenotype required
for normal GI motility in aged mice.
PLOS ONE | DOI:10.1371/journal.pone.0115563 February 6, 2015 1 / 21
OPEN ACCESS
Citation: Yamaji M, Mahmoud M, Evans IM, Zachary
IC (2015) Neuropilin 1 Is Essential for Gastrointestinal
Smooth Muscle Contractility and Motility in Aged
Mice. PLoS ONE 10(2): e0115563. doi:10.1371/jour-
nal.pone.0115563
Academic Editor: Michael R. Ruggieri, Temple Uni-
versity School of Medicine, UNITED STATES
Received: August 19, 2014
Accepted: November 25, 2014
Published: February 6, 2015
Copyright: © 2015 Yamaji et al. This is an open ac-
cess article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by British Heart
Foundation programme grant RG/06/003 to I.Z. (M.Y.,
M.M., I.M.E.). The funders had no role in study de-
sign, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
Neuropilin 1 (NRP1) is a transmembrane glycoprotein receptor for two types of ligands, the
class 3 semaphorins which regulate axonal guidance and neuronal patterning during develop-
ment [1,2], and members of the VEGF family of angiogenic cytokines in endothelial cells [3].
Nrp1-null mice die between embryonic day (E) 10.5 and E14.5, dependent on the genetic back-
ground, with a spectrum of cardiovascular and neuronal defects [4,5]. Mice with loss of Nrp1
in vascular endothelial cells are also embryonic lethal due to aberrant cardiovascular develop-
ment [6]. Mice heterozygous for Nrp1 are viable and fertile with no discernible spontaneous
phenotype, but exhibit increased mortality when challenged by cardiac pressure overload [7].
The precise cellular function of NRP1 is unclear, but it plays an essential role in endothelial cell
motility [8,9,10], and in growth cone collapse in sensory neurons [1].
Recent evidence indicates that NRP1 is expressed in other cell types [8], including smooth
muscle cells (SMC) [11,12,13,14,15]. NRP1 is highly expressed in human aortic and coronary
artery SMC [12,13,14] and inhibition of NRP1 function decreases the migratory and signaling
responses of SMC to PDGF-BB [12]. In vivo, apart from neurons, epicardium and endotheli-
um, Nrp1 is reported to be most strongly expressed in late mouse embryos in the SMC of large
vessels [15]. However, the functional role of NRP1 in SMC either in the vasculature, the gastro-
intestinal (GI) tract or in other organs is currently unknown.
Smooth muscle is essential for the contractility of blood vessels, the uterus, and the organs
of the GI tract, including the small and large intestines, the bladder and the urinary tract. Peri-
staltic gut motility, essential for the movement and digestion of food, and the excretion of solid
waste, occurs as a result of the co-ordinated action of the circular and longitudinal smooth
muscle layers in the GI wall. Genetically-targeted deficiency of components of the smooth
muscle contractile apparatus, such as myosin light chain kinase (MLCK) [16], or smoothelin
[17], causes defects in gut smooth muscle organisation associated with impaired GI contractili-
ty and motility.
Since NRP1 is expressed in SMC, we sought to investigate its role in SMC functions in vivo
by generating mice with a SMC-specific loss of Nrp1 (Nrp1SMKO). These mice were viable,
healthy, with no overt phenotype during early post-natal life. Unexpectedly, however,
Nrp1SMKOmice developed a pronounced age-dependent defect in GI motility. Further stud-
ies of GI SMC function in aged Nrp1SMKO mice revealed marked defects in intestinal length
and SMC architecture, combined with impaired GI motility and SMC contractility. These de-
fects in GI tissue and function were associated with changes in expression of markers of SMC
phenotypes indicating that loss of Nrp1 caused a switch to a less contractile SMC phenotype.
Furthermore, examination of early post-natal mice revealed changes indicative of a similar
early shift to a less contractile phenotype in Nrp1SMKOmice. These results show that NRP1 is
essential for maintenance of the visceral SMC contractile phenotype and of the contractile
functions of SMC required for normal GI motility
Materials and Methods
This work was performed under UK Home Office Licence 70/7700, following full ethical ap-
proval by the University College London (UCL) Animal Welfare and Ethical Review Body, and
review by the UK Home Office.
Generation of SMC specific Nrp1 knockout mice
Animal experiments were conducted in accordance with the Animal Care and Ethics Guide-
lines of University College London (UCL) and the United Kingdom Home Office Animals
(Scientific Procedures) Act (1986). In order to generate SMC-specific Nrp1 knockout mice, two
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successive rounds of breeding were performed (Fig. 1B). First, we crossed heterozygous male
smooth muscle myosin heavy chain (smMHC)-Cre/enhanced green fluorescent protein
(eGFP) transgenic mice (smMHC-Cre+/−) [18,19,20] with homozygous female floxed Nrp1
(Nrp1fl/fl)mice [6]. The resulting offspring that are SMC-specific Nrp1 heterozygotes
(smMHC-Cre+/−; Nrp1fl/+) were healthy, viable and fertile. Male smMHC-Cre+/−; Nrp1fl/+ mice,
that were generated from the first cross, were then bred with female Nrp1fl/fl mice to generate
SMC-specific Nrp1 knockout mice (smMHC-Cre+/−; Nrp1fl/fl). In smMHC-Cre/eGFP transgen-
ic mice, transient expression of Cre recombinase occurs in the germ cells with expression end-
ing prior to fertilization [19]. Therefore, any floxed allele transmitted from the Cre-expressing
parent will be recombined (whether the haploid male germ cell is Cre-positive or Cre-nega-
tive), resulting in a null allele of Nrp1 (hereafter referred to as -) in all tissues and giving rise to
mice heterozygous for global Nrp1 deficiency. Since Cre activity stops prior to fertilization, the
resulting offspring will exhibit no universal deletion of any floxed allele of maternal origin.
Consequently, in the second breeding round four different genotypes were generated:
smMHC-Cre+/−;Nrp1fl/− (SMC-specific Nrp1 knockout and also globally heterozygous for
Nrp1; hereafter designated Nrp1SMKO), smMHC-Cre−/−;Nrp1fl/− (globally Nrp1 heterozygous,
designated Nrp1+/−) which we used as the controls for the SMC-specific Nrp1 knockout and
globally Nrp1 heterozygous mice (Nrp1SMKO); smMHC-Cre+/−;Nrp1fl/+ (SMC-specific Nrp1
heterozygous, designated Nrp1SMHET), and smMHC-Cre−/−;Nrp1fl/+ (designated Nrp1fl/+ or
WT). Genotyping of genomic DNA from ear biopsies was performed by polymerase chain re-
action (PCR) (S1 Table).
Protein and Gene Expression
Protein expression was determined in paraffin-embedded sections by immunostaining stain-
ing, and in tissue lysates by immunoblotting, as described [21,22], using primary and conjugat-
ed secondary antibodies as indicated in S2 and S3 Tables. Levels of mRNA were measured in
tissue RNA by quantitative real-time PCR (qPCR) using the primers indicated (S4 Table) as
described [22,23], or by semi-quantitative reverse-transcription PCR (RT-PCR).
In vivo BrdU labelling
Proliferating cells in the colon were detected in P4, P7 and adult (6M) mice by immunostaining
bromodeoxyuridine (BrdU) following intraperitoneal BrdU injection. To detect proliferating
cells, each mouse was injected intraperitoneally with 100μg/g body weight bromodeoxyuridine
(BrdU) (Sigma, #B5002) 4 hours before harvesting the tissue. Tissue sections were treated with
2M HCl for 45 minutes followed by incubation with 0.1M Boric acid for 30 minutes prior to
immunohistochemistry with anti-BrdU antibody (Dako # M0744). Proliferating cells were
counted in the muscularis externa of the colon,
Measurement of gastric emptying by 24 hour stool collection
Assessment of gastric emptying was carried out as described before [24, 25], except that the
monitoring period was extended to 24 hours. Briefly, mice were placed in a separate clean cage
with regular diet (Harlan) and the faecal output was screened by counting all the faecal pellets
collected after a 24 hour-period. Six faecal pellets from an individual mouse were placed in an
eppendorf tube, air-dried overnight and weighed and measured by an electronic digital caliper.
Role of Neuropilin 1 in Smooth Muscle
PLOS ONE | DOI:10.1371/journal.pone.0115563 February 6, 2015 3 / 21
Role of Neuropilin 1 in Smooth Muscle
PLOS ONE | DOI:10.1371/journal.pone.0115563 February 6, 2015 4 / 21
Measurements of intestinal contractility
Colonic contractility was measured in organ baths containing Krebs-Ringer buffer at 37°C.
Colonic segments were stretched gradually to .5–1.0g tension and challenged with 80mM
potassium chloride (KCl). Increasing doses of carbachol (CCh) or KCl were then administered.
Changes in isometric tension were measured and recorded by LabChart software (AD Instru-
ments Ltd., Oxford).
Statistical analyses
Statistical significance was assessed either by repeated measures two-way analysis of variance
followed by Bonferroni’s Multiple Comparison Test, or two-tailed Student t test. When the in-
teraction was found significant in repeated measures two-way analysis of variance, one-tailed
paired Student t test was performed. The significance of association between SMB isoform ex-
pression and the genotype was analysed in a 2×2 contingency table using a chi-squared test.
P<.05 was considered statistically significant.
Results
SMC-specific targeting of Nrp1 in mice
The smMHC-Cre/eGFP mouse line, expressing Cre recombinase under the control of the
smooth muscle-specific myosin heavy chain promoter [18,20], has been widely used to create
SMC-specific conditional gene deletions [26,27]. Therefore, to determine the role of Nrp1 in
SMC in vivo we generated mice harbouring a deletion of Nrp1 in SMC by crossing Nrp1 floxed
mice [6] with smMHC-Cre/eGFP transgenic mice (Fig. 1A-C). Analysis of over 100 offspring
from 15 breeding groups showed that the genotypes of weaned animals occurred close to ex-
pected Mendelian ratios (S5 Table).
Determination of eGFP expression in smMHC-Cre/eGFP mice confirmed that Cre
recombinase activity was restricted to smooth muscle-rich tissues, including the large arteries,
colon, bladder and uterus (Fig. 1D). To further verify restriction of Cre recombinase activity to
SMC, smMHC-Cre/eGFP mice were crossed with ROSA26 Cre reporter mice [28]. Analysis of
beta-galactosidase activity in the progeny of this cross demonstrated efficient recombination of
the ROSA26 reporter allele in SMC-rich regions of the colon and thoracic aorta; additionally,
immunohostochemical staining of SMC-specific alpha-actin (SMA) and NRP1 on serial tissue
sections confirmed the co-localisation of NRP1-positive SMC with beta-galactosidase activity
in these tissues (Fig. 1E).
The efficiency of recombination of the Nrp1 floxed alleles by Cre recombinase was verified
by measurement of Nrp1mRNA and protein expression. Nrp1mRNA levels in the colon, mea-
sured using qPCR, were markedly reduced both in mice that had a SMC-specific Nrp1
Figure 1. Conditional targeting ofNrp1 in SMC. (A) Schematic diagram of the targeting strategy to generateNrp1SMKOmice. The structure of the NRP1
protein shows the major domains in the extracellular (EC), the transmembrane (TM) and cytoplasmic (Cyt) domains. In floxedNrp1 (Nrp1fl) mice, the exon2 of
Nrp1 is flanked by two loxP sites, which undergo Cre-mediated recombination in SMCwhen crossed to the smMHC-Cremice, resulting in a nullNrp1 allele. The
positions of primers (F1,F2,R1,R2) used for genotyping are indicated. (B) Breeding scheme used to generateNrp1SMKO and heterozygousNrp1+/− controls. In
the second round of breeding four different genotypes are generated as indicated in parentheses:Nrp1fl/+ (WT),Nrp1SMHET,Nrp1+/−, andNrp1SMKO. (C)
Genotyping of ear notch DNA. A 900bp band indicates the presence of theCre transgene (top gel). PCRwith primers F1 and R1 (middle gel) detects the loxP
site and generates 486bp (Nrp1WT) and 700bp (Nrp1fl, floxed) products. PCRwith primers F2 and R2 (bottom gel) detects Cre-mediated recombination of
floxedNrp1 and generates 986bp (Nrp1WT),*600bp (Nrp1−, recombined) and*1200bp (Nrp1fl, unrecombined). (D) GFP fluorescence in smMHC-Cre+/−
(green) shows that Cre recombinase expression is restricted to vascular and visceral SMC. (E) NRP1/SMA immunohistochemistry and X-gal staining of adult
colon and thoracic aorta. NRP1 (i,iv) and SMA (ii, v), are expressed in both the circular (CM) and longitudinal (LM) muscle layers, and the muscularis mucosae
(arrowhead) of the colon and in the tunicamedia of the thoracic aorta (arrow). (iii, vi) X-gal staining of sections from a smMHC-Cre/Rosa26R double
heterozygote shows that the expression of the lacZ (blue), driven by the smMHC promoter, is restricted to visceral (iii) and vascular (vi) SMC. Boxed regions are
magnified views showing expression of NRP1, SMA and LacZ in smooth muscle cells of the colon.
doi:10.1371/journal.pone.0115563.g001
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knockout and were also globally heterozygous for Nrp1 (Nrp1SMKO) (32.87% ± 10.7%) and in
globally heterozygous Nrp1 mice (Nrp1+/−) (38.93% ± 4.99%), as compared to wild-type
Nrp1fl/+ (100%) (identical to Nrp1+/fl genotype; see Fig.1B) mice (Fig. 2A). The similar loss of
Nrp1mRNA expression in Nrp1SMKO and globally heterozygous Nrp1+/−mice probably reflects
significant expression of Nrp1 in non-SMC cells in the colon such as vascular endothelium and
sensory neurons. Western blotting revealed a striking reduction in NRP1 protein expression in
aortic SMC isolated from thoracic aortae and in whole colon protein lysates in Nrp1SMKO as
compared to Nrp1+/+ mice, which was greater than the loss of NRP1 in Nrp1+/− global hetero-
zygotes (Fig. 2B). Quantification of protein expression in western blots showed that in
Nrp1SMKO mice as compared to Nrp1+/− heterozygotes, colonic NRP1 expression was signifi-
cantly reduced in adult (>18 months) mice (S1A Fig.). Colonic NRP1 protein expression was
also significantly reduced in Nrp1+/− heterozygotes (p< 0.001) and in Nrp1SMKO (p< 0.001)
post-natal day (P) 7 pups as compared to wild-type (WT) Nrp1fl/+ pups. Immunohistochemical
staining for NRP1 also revealed a marked reduction in NRP1 expression in the visceral SMC of
Figure 2. Reduced SMC-specificNrp1 expression inNrp1SMKO. (A) qPCR analysis on the whole adult colon: means±SD, n = 3, *P<.05, **P<.005,
***P<.001. (B) Western blots of NRP1 in the isolated smooth muscle layer from the thoracic aorta and in whole colon tissue samples frommice>18 months
old. (C) Reduced expression of NRP1 in visceral SMCs is detected by immunohistochemical staining of adult colon tissue sections. Reduced expression,
specifically in SMCs, is evident in theNrp1SMKO (iii) sample when compared to theNrp1fl/+ (i) andNrp1+/− (ii) samples, and no change in NRP1 expression
can be seen in the myenteric plexus of Auerbach (indicated by the arrows).
doi:10.1371/journal.pone.0115563.g002
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colons from Nrp1SMKO compared with WT Nrp1fl/+ mice and Nrp1+/− heterozygotes (Fig. 2C).
Double immunofluorescent staining in colon sections for NRP1 and SMA also showed co-
staining of NRP1 expression and SMA in smooth muscle layers of the colon in WTmice
(S1B Fig.). We also cultured visceral SMCs from smooth muscle strips prepared from the blad-
ders of P7 neonatal pups with different genotypes. As shown in S1C Fig., in these purer SMC
cultures, expression of a major 130 kDa NRP1-immunoreactive band was reduced in Nrp1+/−
heterozygotes compared with WT Nrp1fl/+ mice, and was more strongly decreased in SMC
from Nrp1SMKO mice. In whole colon extracts prepared from the same pups, western blots sim-
ilarly showed a clear reduction in NRP1 expression in Nrp1SMKO mice (S1C Fig.). Additionally,
we examined NRP1 expression in primary cultures of human colonic SMCs. NRP1-immunore-
active bands of 130kDa typical of full-length NRP1 as well as a higher molecular weight band
of*250 kDa corresponding to glycosylated NRP1 and previously reported in human vascular
SMC [12], were readily detected in human colonic SMCs, and their specificity was confirmed
by effective knockdown using NRP1-targeted siRNA (S1D Fig.). These results indicated that
NRP1 is expressed in gastrointestinal SMC in both neonatal and adult mice, and also demon-
strated that we had generated a model of SMC-specific Nrp1 deficiency. In all subsequent anal-
yses, mice with SMC-specific Nrp1 deficiency combined with global heterozygous loss of Nrp1
(smMHC-Cre+/−;Nrp1fl/−, designated Nrp1SMKO) were compared with global Nrp1 heterozy-
gotes (smMHC-Cre−/−;Nrp1fl/−, designated Nrp1+/−), with additional comparisons with WT
Nrp1fl/+ mice (smMHC-Cre−/−;Nrp1fl/+, designated Nrp1fl/+). See “Materials and Methods” for
full descriptions of the mouse genotypes used.
Nrp1SMKOmice display a reduced rate of gastric emptying and develop
lower GI tract abnormalities
Nrp1SMKO mutants were viable and fertile and appeared to develop normally and undergo nor-
mal post-natal growth. No overt vascular abnormalities were observed in adults either in large
vessels, such as the aorta, or in the adult retinal vasculature (results not shown). However, by
18 months of age Nrp1SMKO mice exhibited abdominal distension and a significantly reduced
rate of gastric emptying, indicated by reduced overnight stool count (Fig. 3A), larger stools
with a significantly greater mean weight, and significantly reduced total overnight stool weight
compared to their Nrp1+/− controls and WT Nrp1fl/+ mice (Fig. 3B, S2A-B Fig.). At 5–8
months, stool width and length showed no significant differences in the Nrp1SMKO mutants
compared to the heterozygous controls (S2C Fig.), whereas in 8–12 month old mice stool
width was significantly greater in the Nrp1SMKO mutants (Fig. 3B). The difference in size be-
came more pronounced with increasing age, and by 18–22 months of age stool length
(P<.0001) and width (P<.0009) mice were significantly greater in Nrp1+/−;SMKO compared to
Nrp1+/−mice (Fig. 3C). We did not observe any detectable significant differences in the total
weights of older Nrp1SMKO compared to Nrp1+/−mice or WT Nrp1fl/+ mice (S2D Fig.).
Examination of the GI tract in18 month-old mice revealed a grossly enlarged colon in the
Nrp1SMKO mutants, as well as a significantly distended bladder (Fig. 3C-D). In contrast, control
Nrp1+/− and WT Nrp1fl/+ mice showed normal colon and bladder of healthy appearance. Fur-
ther macroscopic examination of Nrp1SMKOmice revealed a significantly shorter small intestine
and colon as well as a significantly dilated colon, in which the stool had become impacted and
hardened towards the rectum leading to severe constipation (Fig. 3E). In comparison, the co-
lons of the controls contained stool that had formed into pellets as it reached the rectum
(Fig. 3E).
To examine whether Nrp1 deficiency affected the GI smooth muscle architecture and orga-
nisation colonic tissue sections from18 month-old Nrp1SMKO mutants and their controls
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were collected and stained for α-SMA. Analysis of similar regions of the colon in Nrp1SMKO
and heterozygous Nrp1+/−mice that were not filled with faeces, a method similar to that re-
ported in other studies [29], revealed a significantly enlarged lumen size in the Nrp1SMKO mu-
tants, consistent with the grossly enlarged colon observed upon dissection, as well as a
complete lack of transverse folds that are normally supported by the muscularis mucosae and a
significant thinning of the SMC layer in the muscularis externa (Fig. 4A). Immunofluorescent
staining showed that SMC in the colons of Nrp1SMKO mice had a less elongated shape and were
less tightly organised compared with heterozygous Nrp1+/−mice, characteristic of SMC that
are hypertrophic (Fig. 4B). Examination of SMC associated with colonic submucosal blood ves-
sels indicated that both the architecture of these vessels, the SMC content, and the number of
vessels were grossly normal in Nrp1SMKO mice as compared with Nrp1+/− heterozygotes and
WT Nrp1fl/+ mice (results not shown).
We also investigated the organisation of enteric neurons in Nrp1SMKO mutants by staining
for Class III beta-tubulin, encoded by the Tubb3 gene, using an antibody that specifically recog-
nises neurons in the adult mouse intestine [30,31]. TUBB3 staining of Nrp1fl/+ and Nrp1+/−
colon sections revealed clusters of neurons at the interface between circular and longitudinal
smooth muscle layers, and neurons interspersed within the circular smooth muscle. TUBB3-
positive neurons in Nrp1SMKO mice had a flattened and elongated appearance (S3A Fig.). Ex-
amination of Tubb3mRNA and TUBB3 protein expression showed no significant decrease in
expression in Nrp1SMKO as compared to heterozygous Nrp1+/−mice (S3B and C Fig.). Further-
more, determination of the expression of the pan neuron-specific markers, HuC and HuD,
using qPCR also revealed no specific differences between Nrp1SMKO as compared to heterozy-
gous Nrp1+/−mice (S3D-E Fig.).
Loss of Nrp1 in SMC reduces GI smooth muscle contractility
The Nrp1SMKO mutants exhibit characteristics of severe gut dysmotility resulting in weakened
peristaltic propulsion along the gut and indicating reduced or defective contractility. Ex vivo
analysis of colonic ring contraction in response to KCl and the cholinergic agonist, CCh, re-
vealed reduced contractile responses in the Nrp1SMKO mutants compared with controls
(Fig. 5). A significant difference in the mean contractile tension during KCl depolarisation be-
tween Nrp1SMKO and heterozygous Nrp1+/−mice (18 month-old) was observed at 80mM KCl
(Nrp1SMKO: .7±g, Nrp1+/−: 1.5±g, P<.005) at which the maximal contraction was induced (data
not shown), and a trend towards a decrease was observed at 48 mM KCl (Fig. 5A). The contrac-
tile response to CCh was also significantly reduced in the Nrp1SMKO mutants compared to
Nrp1+/− controls at 3μM (Fig. 5B; Nrp1SMKO: EC50 5.971e−.07, Nrp1+/−: EC50 4.085e−.07,
P<.01). Furthermore, the amplitude of spontaneous contractile activity from the Nrp1SMKO
mutants was reduced when compared to that of heterozygous Nrp1+/− controls (Fig. 5C). The
spontaneous contractility of colonic rings from the heterozygous Nrp1+/− controls was similar
to that of WT Nrp1fl/+ mice (S4 Fig.).
Figure 3. SMC-specific knockout of Nrp1 causes severe constipation and GI tract malformations. (A) Overnight stool counts from18 month-old
mice. Mice were housed in a clean cage 24 hours before harvesting the stools. Differences betweenNrp1SMKO and the controls were significant (***P<.001,
n3). (B) Stool size measurement from 8–12 month- and 18–22 months-old mice. Each dot represents an average of six stools collected from one animal.
(****P<.0001, ***P<.001, *P = .01). (C) Bladder length comparison between18 month-old Nrp1SMKO and the controls, *P = .0217, n6. (D)
Macroscopic images of dissected Nrp1fl/+, Nrp1+/− andNrp1SMKO(18 months). The colon (Col) and the bladder (Bl) were severely dilated inNrp1SMKO. (E)
The entire GI tract was dissected from20 months-oldNrp1fl/+, Nrp1+/− andNrp1SMKOmice. The arrows point to well-pelleted faeces in the colon of the
Nrp1fl/+ andNrp1+/− controls, whileNrp1SMKO displayed an impacted colon and caecum (Ce). The length of the colon and small intestine was significantly
shorter in theNrp1SMKO than the controls (**P<.01, n3). The width of the proximal colon was also significantly larger in the Nrp1SMKO compared to the
controls (***P<.0001, n3).
doi:10.1371/journal.pone.0115563.g003
Role of Neuropilin 1 in Smooth Muscle
PLOS ONE | DOI:10.1371/journal.pone.0115563 February 6, 2015 9 / 21
Occurrence of an immature SMC phenotype in early post-natal
Nrp1+/−;SMKOmice
We hypothesised that the impaired GI motility and contractility observed in adult Nrp1SMKO
mice might result from phenotypic changes in SMC due to loss of Nrp1 which had developed
at an earlier stage of development. To determine when changes in smooth muscle began to
occur in Nrp1SMKO mutants we measured the lengths of the colon and small intestine in
Figure 4. SMC-specific knockout of Nrp1 leads to defects in smoothmuscle morphology. (A) SMA immunohistochemistry on cross-sections of adult
colon (18 months). Arrow points to the muscularis externa, which was significantly thinner inNrp1SMKO (*P<0.05,Nrp1fl/+ n = 4; Nrp1+/− n = 5; Nrp1SMKO
n = 5). The lumen size (asterisk) was significantly larger in theNrp1SMKO: means±SD, *P<0.05, Nrp1fl/+ n = 3;Nrp1+/− n = 4; Nrp1SMKO n = 4. (B) SMA
immunofluorescent staining of colonic tissue sections.
doi:10.1371/journal.pone.0115563.g004
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Figure 5. Decreased colonic contractility inNrp1SMKO.Organ bath experiments showing the colonic contractile response to increasing doses of KCl (A)
and CCh (B) inNrp1SMKO andNrp1+/−mice (means±SEM). A significant difference in the contractile tension in response to KCl was observed at 80mM (A,
*P = .0359, n = 3). (B) Colonic segments of Nrp1SMKO had a significantly reduced contractility in response to CCh at 3μM (*P<.05, **P = .0088, n = 4). (C)
Representative spontaneous contractions are shown for colonic segments from three differentNrp1SMKO andNrp1+/− littermates.
doi:10.1371/journal.pone.0115563.g005
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postnatal day (P)7 pups and 6 month-old mice. No significant differences were observed in the
length of the small intestine or colon in the Nrp1SMKO mutants compared to their littermate
Nrp1+/− controls at P7 (S5A Fig.). However, at 6 months of age the lengths of the small intestine
and colon were significantly reduced in Nrp1SMKO mice, though no significant change in colon
width was detected at that age (S5B Fig.). These results pointed to earlier defects in the struc-
ture of the GI tract in Nrp1SMKO mice, which progressively worsened over time resulting in the
severe functional GI defects observed in later adult life.
The GI tract continues to develop after birth, as it adapts to changes in the gut microbiota
and food composition at weaning, and reaches maturity in adulthood [32,33]. During GI devel-
opment, SMC initially possess a less differentiated or synthetic phenotype characterised by a
greater proliferative potential, and subsequently differentiate to acquire a contractile phenotype
as the intestine matures into adulthood [34]. The defects we observed in Nrp1SMKO mice im-
plied a possible defect in SMC differentiation which had long term consequences for SMC con-
tractility. To investigate early changes in the phenotype of GI tract SMC we analysed both
SMC proliferation and the expression of well-characterised protein markers of synthetic and
contractile SMC in early postnatal pups. At P4 the proliferation of colonic SMC, assessed by in
vivo BrdU labelling, was similar between Nrp1SMKO and Nrp1+/−mice (Fig. 6A). However, at
P7 a significant increase in the number of proliferating SMC was detected in the Nrp1SMKOmu-
tants compared to the controls, with SMC proliferation in Nrp1SMKO mice remaining at a level
similar to that observed at P4, whereas proliferating SMC had decreased in the controls
(Fig. 6B). We next quantified the colonic protein expression of the non-muscle myosin heavy
chain B, SMEMB, a marker of de-differentiated or synthetic SMC [34]. Western blotting of
bladder tissue extracts revealed a significant increase in SMEMB expression in P7 Nrp1SMKO
pups as compared to their P7 globally heterozygous Nrp1+/− littermates (Fig. 6C, S6A Fig.). We
also observed an increase in SMEMB expression in colonic tissue extracts from late adult (16
months-old) Nrp1SMKO mice (Fig. 6D), though this increase was not statistically significant
(S6B Fig.). No significant differences were detected in colonic SMC proliferation in adult mice,
and it was noted that both adult heterozygous Nrp1+/− control mice and Nrp1SMKO mutants
possessed no or very few proliferating colonic SMC, though abundant proliferating cells were
detected in the epithelial layers of the colon (S7 Fig.). These results point to a delay in the matu-
ration/differentiation of GI tract SMC and persistence of a synthetic and proliferative SMC
phenotype in Nrp1SMKO mice.
Reduced expression of contractile SMCmarkers in Nrp1+/−;SMKOmice
The delay in SMC differentiation and persistence of a more immature SMC phenotype ob-
served in P7 Nrp1SMKO mutants, raised the possibility that a less differentiated SMC phenotype
was maintained into later adult life, and could thereby explain the long-term effects of Nrp1
SMC-specific deficiency on GI motility. We therefore examined the expression of markers of
both contractile/differentiated and synthetic/de-differentiated SMC phenotypes in greater de-
tail in adult mice (16–22M). Two widely studied markers of contractile SMC are smMHC and
Sm22alpha [35]. Q-PCR analysis of smMHC and Sm22alphamRNA expression levels in colon-
ic tissue extracts revealed a significant reduction of both contractile SMC markers in the
Nrp1+/−;SMKO mutants (SmMHC expression levels: Nrp1fl/+ 99.6% ± 0.89%; Nrp1+/− 73.96% ±
8.79%; Nrp1SMKO 52.16% ± 19.05%. Sm22α expression levels; Nrp1fl/+ 102.1% ± 3.6%; Nrp1+/−
93.38% ± 14.18%; Nrp1SMKO 54.19% ± 22.53%) (Fig. 7A). A reduction of smMHC protein ex-
pression in the colonic SMC of Nrp1SMKO mutants was also detected using immunohistochem-
ical staining (Fig. 7B). In contrast expression of SMA, which is expressed at similar levels in
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synthetic and contractile SMC and does not differentiate between the two phenotypes, was un-
affected in Nrp1SMKO mice.
We next investigated the relative expression of the SMA and SMB smMHC isoforms. The
SMB isoform has higher ATPase activity [36,37], and is expressed in phasic smooth muscles
(intestinal SMC) but absent in tonic smooth muscles (VSMC) [38]. We examined colonic SMA
and SMB isoform expression from16 month-old mice by PCR. We detected expression of
Figure 6. SMC proliferation and expression of SMEMB. (A) BrdU staining of colonic tissue sections at P4 (means±SD, n3). (B) Analysis of proliferation
at P7 revealed a significant increase in SMC proliferation inNrp1SMKO compared to the littermate controls (means±SD, *P = .0146, n = 3). (C,D) Western
blots of SMEMB in bladder tissue extracts from P7 pups (C) and colonic extracts from adult (16 months, D) mice (n3).
doi:10.1371/journal.pone.0115563.g006
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Figure 7. Loss ofNrp1 in SMC affects the expression of markers of contractile phenotype. (A) qPCR analysis of SMC contractile phenotype markers,
smMHC (n = 5) and Sm22-alpha (n3), on colonic samples frommice16 months old: means±SD; *P<.05, **P<.005, ***P = .0005. (B) smMHC/SMA
immunohistochemistry in colonic tissue from16 months old mice. (C) Semi-quantitative RT-PCR for the SMA and SMB smMHC isoforms in whole colon
cDNA from16 month-old mice. Representative results are shown from 3 mice (Nrp1fl/+, n = 4; Nrp1+/−, n = 6; Nrp1SMKO, n = 6; *P = .04). (D)
Immunofluorescent staining of SK3 and SMA in colons of16 months old mice shows enhanced expression of SK3 in the colonic SMC (arrows) of Nrp1SMKO
compared to Nrp1+/− controls. (E) Western blot of SK3 expression in colon lysates from16 month-old mice. Densitometric quantification of SK3 was
normalised to beta-actin expression: means±SD; *P = .0233, n = 4.
doi:10.1371/journal.pone.0115563.g007
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the SMA isoform in all the samples analysed. However, whilst unambiguous expression of the
SMB isoform was observed in50% of the heterozygous Nrp1+/− samples analysed, in contrast,
no expression of the SMB isoform could be detected in any of the Nrp1SMKO samples (Fig. 7C).
Loss of contractility in Nrp1SMKO mutants might also be due in part to a perturbation of the
mechanisms regulating vascular tone. SK3 is a small conductance calcium-activated potassium
channel, important for inhibitory neurotransmission in GI SMC, and is expressed in both the
circular and longitudinal SMC in the murine small intestine and proximal colon [39,40]. Sever-
al studies indicate that SK3 channels regulate muscle tone in vascular and visceral smooth mus-
cle, and that SK inhibition results in enhanced vasoconstriction and visceral smooth muscle
contraction [41,42]. To examine the expression of SK3 in the Nrp1SMKO mutants, we per-
formed double immunofluorescence labelling of colonic tissue sections for SK3 and SMA in
16 month-old mice. We observed increased expression of SK3 in both the circular and
longitudinal SMC of Nrp1SMKO mice compared with littermate heterozygous Nrp1+/− controls
(Fig. 7D). Furthermore, western blotting of colonic tissue extracts detected a significant in-
crease in SK3 protein expression in Nrp1SMKO as compared with heterozygous Nrp1+/−mice
(approximately a 2 fold increase) (Fig. 7E). This increased expression of SK3 likely contributes
to the motility dysfunction seen in the colons of the Nrp1+/−;SMKO mutants. Changes in SK3 ex-
pression could arise from an expansion of SMC co-expressing PDGFR-alpha due to PDGF-A
driven cell proliferation and/or migration of these cells. This possibility was examined by deter-
mining the levels of colonic PDGFR-alpha using qPCR. The results showed no significant dif-
ferences in the mRNA expression of PDGFR-alpha in Nrp1SMKO mutants as compared with
WT Nrp1fl/+ or heterozygous Nrp1+/−mice (S8 Fig.).
Discussion
Recent findings indicate that NRP1 is expressed in VSMC, and mediates signaling and migra-
tory responses in SMC to PDGF, raising the possibility that NRP1 plays an important role in
physiological and pathophysiological roles of smooth muscle in vivo. To investigate such a role
we generated mutant mice with a conditional SMC-specific deficiency of Nrp1. Nrp1SMKO mice
were viable with no overt phenotype or significant mortality in development or in early post-
natal life. However, aged mice with SMC-specific loss of Nrp1 unexpectedly exhibited signs of
severely impaired GI motility characterised by increased size and reduced frequency of stool,
reduced contractility of the colon, enlargement of the bladder and a distended and shortened
large and small intestine, defects that were associated with a marked reduction in the thickness
of the muscularis externa smooth muscle layer of the colon. Collectively, these defects indicate
an essential role of NRP1 in the SMC of the gut in maintaining both healthy GI function and
the normal architecture of visceral smooth muscle in later adult life.
Analysis of markers of the contractile and synthetic/proliferative phenotypes indicated that
loss of Nrp1 in SMC resulted in a shift of gut SMC to a less contractile and more synthetic
state. In particular, the reduced expression in Nrp1SMKO mice of smMHC and its SMB isoform
is consistent with the reduced colonic contractility in these mutants. The SMB isoform is ex-
pressed mainly in bladder, intestine, stomach, and small muscular arteries, and is the predomi-
nant isoform in intestine [43]. Differential expression of SMA and SMB isoforms may be
related to their different properties in actin-myosin force generation. Thus, SMB containing a 7
amino acid insert, exhibits higher rates of MgATP binding to and MgADP release from the
myosin active site, allowing myosin to transition through the cross-bridge cycle at an increased
rate [44]. This in turn may account for the greater actin filament velocity characteristic of tis-
sues with predominantly phasic smooth muscle (e.g. the gut wall) as compared with tonic
smooth muscle (e.g. most blood vessels). It is also noteworthy that down-regulation of SMB
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isoform expression has been reported in the lethal spotted mouse, a model of Hirschsprung’s
disease, characterised by megacolon and functional obstruction of the colon proximal to the
rectum [45], and in the hypertrophic urinary bladder [46]. The increased expression in
Nrp1SMKO mutants of the small Ca2+-activated K+ channel, SK3, implicated in negative regula-
tion of smooth muscle contraction, further indicates that mechanisms regulating smooth mus-
cle contractility are disrupted in Nrp1SMKO mice. This conclusion is also supported by
immunofluorescent staining of colonic smooth muscle showing that SMC in Nrp1SMKO mice
had a less spindle-shaped appearance and were less closely arranged with larger intercellular
spaces, characteristic of hypertrophic and more synthetic cells. Though mutant mice lacking
Nrp1 in SMC appeared outwardly normal during development and early post-natal and adult
life, we observed increased SMC proliferation and expression of SMemb, a marker of the syn-
thetic phenotype, in early post-natal Nrp1SMKO pups (P7). Furthermore, a significant reduction
in the length of the small and large intestines was observed as early as 6 months in Nrp1SMKO
mice. Together, these findings indicate that loss of Nrp1 in gut SMC causes early post-natal
changes in SMC resulting in a persistent loss of their contractile phenotype in turn contributing
to progressively worsening defects in GI structure and late-onset impairment of GI contractility
and motility. It is plausible that the increased proliferative capacity of SMC in Nrp1SMKO mice
and other changes associated with the synthetic phenotype make intestinal smooth muscle
more susceptible to long-term degenerative processes resulting in thinning of the intestinal
smooth muscle layer and loss of function. Since gastrointestinal SMC express PDGFRα and its
major ligand PDGF-A, changes in SK3 expression might be due to expansion of SMC or non-
SMC co-expressing PDGFR-alpha due to PDGF-A driven cell proliferation and/or migration.
Though we found no significant changes Pdgfr-alphamRNA expression in Nrp1SMKO mutants
as compared with WT Nrp1fl/+ or globally heterozygous Nrp1+/−mice, it is plausible that
PDGF-A signaling via PDGFRαmay play a role in increasing SK3 expression, and in promot-
ing a switch in gastrointestinal SMC to a more synthetic, less differentiated phenotype. This
possibility warrants further study. Though we did not observe gross changes in the early post-
natal GI tract, further investigation of the role of Nrp1 in the early stages of GI development
may be warranted. It is of interest that mice null for Nrp2 exhibited enhanced bladder smooth
muscle contractility [47]. We did not examine bladder contractility in our study, but the disten-
sion of the bladder observed in Nrp1SMKO mice is consistent with the other pathological GI fea-
tures described herein. It is possible therefore that NRP1 and NRP2 may play different, even
opposing, roles in regulating visceral smooth muscle function.
The viability and apparently normal development of Nrp1SMKO mice indicates that loss of
Nrp1 expression in SMC does not significantly impact upon cardiovascular development, an-
giogenesis, or arteriogenesis, though we do not preclude the possibility that targeted deletion of
Nrp1 in SMC may have more subtle or organ-specific effects on cardiovascular integrity and
development. Furthermore, it is plausible that residual SMC NRP1 expression perhaps due to
incomplete Cre-mediated deletion of Nrp1 in our model is sufficient to perform some key func-
tions of NRP1 during embryonic and post-natal development.
Chronic obstruction of the large bowel and severe constipation in humans can be caused by
defects either in the enteric nervous system or in the smooth muscle. Hirschsprung’s disease,
the main genetic cause of chronic life-endangering constipation with a frequency of 1:5000 live
births, results in many cases from mutations in specific genes, such as Ret or Gdnf, implicated
in differentiation or patterning of the enteric nervous system, giving rise to an aganglionic
megacolon [48,49]. In contrast, the genetic or other causes of GI motility disorders of myogenic
origin are largely unknown. While Hirschsprung’s disease usually presents in infancy, chronic
idiopathic intestinal motility disorders of myogenic origin occur in adults, though rarely, and
are associated with visceral myopathy, including atrophy and degeneration of the intestinal
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smooth muscle layers [50,51]. The aberrant features of the GI tract observed in Nrp1SMKO mice
are similar, though less severe and later in onset, to the phenotype of mice with SMC-specific
deletion of Serum Response Factor (SRF), a transcription factor for many contractile SMC
genes [29]. SRFSMKO mice exhibited chronic intestinal pseudo-obstruction (CIPO) resulting in
cachexia and death between P13 to P22, and associated with decreased intestinal length and
dilation of the large bowel, thinning of the intestinal SMC layer and reduced intestinal
contractility. Several of these defects are similar to those observed in Nrp1SMKO mice and in
human CIPO. The loss of SMC-specific markers in intestinal SMC is associated with some
forms of human GI motility dysfunction. For example, reduced jejunal α-SMA expression has
been reported in idiopathic CIPO [52]. The role of NRP1 in human gastrointestinal SMC
function is unknown, but we found strong expression of NRP1 in primary cultures of human
colonic SMC (S1 Fig.). Our findings raise the possibility that loss of Nrp1 in visceral smooth
muscle could potentially be an underlying contributor to myopathy leading to impaired GI
motility in human CIPO, a possibility that merits future investigation.
This is the first study to report the effects of in vivo loss of Nrp1 in SMC, and the first to
demonstrate a role of Nrp1 in visceral SMC function in vivo. The finding that Nrp1 is impor-
tant for maintenance of adult mouse intestinal contractile smooth muscle function and for
preservation of normal intestinal smooth muscle architecture identifies new roles for this mole-
cule in vivo. Though we have not defined the precise mechanism involved, our results indicate
a role for this molecule in promoting the sustained transition of visceral SMC to a more con-
tractile phenotype from early post-natal life. This suggests that NRP1 mediates the actions of
an extracellular factor or factors that promote differentiation of visceral SMC to the mature
contractile state required for their functions in later adult life. Defining those differentiation
factors that act via NRP1 in visceral SMC should be a focus of future research.
Supporting Information
S1 Fig. Expression of NRP1 in gastrointestinal SMC. A. Densitometry analysis shows a sig-
nificant reduction in NRP1 protein expression in colonic tissue extracts from Nrp1SMKO adult
mice (>18 months-old) compared to Nrp1+/− controls (P = .041). B. NRP1 protein is express-
ed in colonic smooth muscle cells as detected by immunofluorescence staining of colonic tissue
sections from wild-type adult (5–6 months-old) mice. C. Western blotting also confirmed ex-
pression of NRP1 in extracts from purified murine bladder smooth muscle cells and whole co-
lonic tissue from postnatal day 7 pups, this expression was markedly reduced in tissue extracts
from Nrp1+/− and Nrp1SMKO littermates. D. NRP1 protein is also expressed in human colonic
smooth muscle cells and is efficiently knocked down following treatment of the cells with
siNRP1.
(TIFF)
S2 Fig. Effects of SMC-specific Nrp1 knock out on stool weight, stool size and body weight.
Mean stool weight was significantly larger inNrp1SMKOmice compared toNrp1+/− andNrp1fl/+
controls (A, means ±SD, n = 6, P<.05) reflecting the larger stool size of these mice. Total weight
of overnight stool (mean stool weight multiplied by total number of stools) inNrp1+/−;SMKO
mice was significantly reduced compared toNrp1fl/+ andNrp1+/− controls (B, means ±SD, n4,
P<.05), reflecting the reduction in overnight stool number which is likely due to slow gastric
motility. No significant difference in stool length or width (C) could be detected inNrp1SMKO
mice at 5–8 months of age (n = 4). No significant difference in body weight was detected in aged
(>14 months-old) Nrp1SMKOmice compared toNrp1+/− and Nrp1fl/+ controls (D, means ±SD,
n5).
(TIFF)
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S3 Fig. Nrp1 deficiency in SMC did not significantly affect expression of neuronal markers.
Class III beta-tubulin/TUBB3 immunostaining of colon sections revealed an aberrant staining
pattern in Nrp1SMKO compared to controls (A), but Nrp1 deficiency in SMC did not significant-
ly affect Tubb3mRNA (B, means±SD, n = 4) and protein (C, n = 3) expression. Expression of
the pan-neuronal markersHuC (D) and HuD (E) were also not significantly different between
Nrp1fl/+, Nrp1+/− and Nrp1SMKO mice (16–22 months-old), as determined by Q-PCR of mRNA
prepared from whole colon extracts.
(TIFF)
S4 Fig. Spontaneous colonic contractility in WT Nrp1fl/+, Nrp1+/− and Nrp1SMKOmice
(18 months-old). The amplitude of spontaneous contractile activity was measured in colonic
ring segments from Nrp1fl/+. Nrp1+/− and Nrp1SMKO mice in organ bath experiments. The
spontaneous contractile activity was similar between Nrp1fl/+ and Nrp1+/−mice and markedly
different from Nrp1SMKO mice.
(TIFF)
S5 Fig. Intestinal length in P7 and 6 months-old mice. A) No changes in the length of small
intestine (P = .3344, n = 3) and colon (P = .8058, n = 3) were detected in P7 Nrp1SMKO com-
pared to their littermate controls. B) At 6 months of age Nrp1SMKO mutants began to display a
significant shortening of the small intestine (P<.0001, n6) and colon length (P<.05,
n5) compared to the littermate controls, but no significant changes in the colon width were
detected (P = .4335, n6).
(TIFF)
S6 Fig. Quantification by densitometry analysis of SMEMB protein expression. A. A signifi-
cant increase in SMEMB expression was detected in bladder tissue extracts from P7 Nrp1SMKO
neonates compared to their littermate controls (P = .0255). B. A trend towards increased
SMEMB expression was also detected in colonic tissue extracts from Nrp1SMKO adult mice
(>16 months-old) compared to controls, however, this did not reach statistical significance.
(TIFF)
S7 Fig. Proliferation of colonic SMC in adult Nrp1SMKO and control mice. BrdU staining of
adult colonic tissue sections showed no significant difference in SMC proliferation between
Nrp1SMKO and control littermates, Nrp1+/−.
(TIFF)
S8 Fig. Colonic Pdgfr-alphamRNA expression. No significant difference was seen in
PDGFR-alpha mRNA levels by Q-PCR in colonic tissue extracts from Nrp1fl/+, Nrp1+/− and
Nrp1SMKO 16–22 months-old mice (mean±SD, n3).
(TIFF)
S1 File. Contains supporting Materials and Methods, Methods 1–5.
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S1 Table. Primers used for DNA genotyping.
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S2 Table. Antibodies used for Western Blotting analyses.
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S3 Table. Antibodies for Immunohistochemistry.
(TIF)
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S4 Table. qPCR and semi-quantitative RT-PCR primers. All primers work at 60°C annealing
temperature.
(TIFF)
S5 Table. Predicted and observed frequencies for each genotype. Predicted and observed fre-
quencies for each genotype, expressed as percentage of the total number of animals genotyped
(total number shown in parentheses). Four different genotypes were generated: Nrp1fl/+,
Nrp1SMHET, Nrp1+/− and Nrp1SMKO close to the expected Mendelian ratio of 1:1:1:1.
(TIFF)
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